Data from the phase III ReNeu trial showed the kinase inhibitor led to an overall response rate of 41% in adult patients and 52% in pediatric patients.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Researchers analyze kidney replacement therapies in pediatric crush syndrome. Their findings emphasized dialysis dependency and pediatric intensive care unit outcomes post-earthquake.
Innovations in craniosynostosis management and cranial vault remodeling have improved diagnosis, preoperative planning and treatment resulting in improved patient outcomes and more personalized care...
Explore new techniques in corneal transplantation, including Descemet’s membrane endothelial keratoplasty and artificial corneas, for treating corneal diseases.